The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995
Open accessAbstract
A total of 1,531 recent clinical isolates of Streptococcus pneumoniae were collected from 33 medical centers nationwide during the winter of 1999–2000 and characterized at a central laboratory. Of these isolates, 34.2% were penicillin nonsusceptible (MIC ≥ 0.12 μg/ml) and 21.5% were high-level resistant (MIC ≥ 2 μg/ml). MICs to all beta-lactam antimicrobials increased as penicillin MICs increased. Resistance rates among non-beta-lactam agents were the following: macrolides, 25.2 to 25.7%; clindamycin, 8.9%; tetracycline, 16.3%; chloramphenicol, 8.3%; and trimethoprim-sulfamethoxazole (TMP-SMX), 30.3%. Resistance to non-beta-lactam agents was higher among penicillin-resistant strains than penicillin-susceptible strains; 22.4% of S. pneumoniae were multiresistant. Resistance to vancomycin and quinupristin-dalfopristin was not detected. Resistance to rifampin was 0.1%. Testing of seven fluoroquinolones resulted in the following rank order of in vitro activity: gemifloxacin > sitafloxacin > moxifloxacin > gatifloxacin > levofloxacin = ciprofloxacin > ofloxacin. For 1.4% of strains, ciprofloxacin MICs were ≥4 μg/ml. The MIC 90 s (MICs at which 90% of isolates were inhibited) of two ketolides were 0.06 μg/ml (ABT773) and 0.12 μg/ml (telithromycin). The MIC 90 of linezolid was 2 μg/ml. Overall, antimicrobial resistance was highest among middle ear fluid and sinus isolates of S. pneumoniae ; lowest resistance rates were noted with isolates from cerebrospinal fluid and blood. Resistant isolates were most often recovered from children 0 to 5 years of age and from patients in the southeastern United States. This study represents a continuation of two previous national studies, one in 1994–1995 and the other in 1997–1998. Resistance rates with S. pneumoniae have increased markedly in the United States during the past 5 years. Increases in resistance from 1994–1995 to 1999–2000 for selected antimicrobial agents were as follows: penicillin, 10.6%; erythromycin, 16.1%; tetracycline, 9.0%; TMP-SMX, 9.1%; and chloramphenicol, 4.0%, the increase in multiresistance was 13.3%. Despite awareness and prevention efforts, antimicrobial resistance with S. pneumoniae continues to increase in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Chen, D. K., McGeer, A., de Azavedo, J. C., & Low, D. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410403 · Cited by 987
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 799
Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F., Martin, R., & Gudiol, F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330802 · Cited by 773
Sutcliffe, J., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1817 · Cited by 619
Hansman, D., & Bullen, M. M. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92346-x · Cited by 499
Doern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482
Self-citationJorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W., & Redding, J. S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2075 · Cited by 310
Self-citationAntimicrobial Resistance of Streptococcus pneumoniae in the United States, 1979-1987
Spika, J. S., Facklam, R. R., Plikaytis, B. D., Oxtoby, M. J., & Pneumococcal Surveillance Working Group (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1273 · Cited by 261
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Grebe, T., & Hakenbeck, R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.829 · Cited by 241
Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae
Kaplan, S. L., & Mason, E. O. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.628 · Cited by 232
Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98
Doern, G. V., Brueggemann, A. B., Huynh, H., Wingert, E., & Rhomberg, P. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0506.990603 · Cited by 188
Self-citationShortridge, V. D., Doern, G. V., Brueggemann, A. B., Beyer, J. M., & Flamm, R. K. (1999) · Clinical Infectious Diseases · doi:10.1086/313452 · Cited by 178
Self-citationNaraqi, S., Kirkpatrick, G. P., & Kabins, S. A. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80513-5 · Cited by 139
Gay, K., Baughman, W., Miller, Y. K., Jackson, D. M., Whitney, C. G., Schuchat, A., Farley, M. M., Tenover, F. C., & Stephens, D. S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315853 · Cited by 130
Alterations in PBP 1A Essential for High-Level Penicillin Resistance in Streptococcus pneumoniae
Smith, A. M., & Klugman, K. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1329 · Cited by 121
Antimicrobial Resistance with Streptococcus Pneumoniae in the United States
Doern, G. V. (2000) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2000-9863 · Cited by 121
Self-citationWaites, K. B., Johnson, C. N., Gray, B. M., Edwards, K. M., Crain, M., & Benjamin, W. H. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.5.1731-1734.2000 · Cited by 50
Cited by
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
The negative impact of antibiotic resistance
Friedman, N. D., Temkin, E., & Carmeli, Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.002 · Cited by 870
Antimicrobial silver nanomaterials
Zheng, K., Setyawati, M. I., Leong, D. T., & Xie, J. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.11.019 · Cited by 703
Metadata
- Authors
- Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2001-06
- Volume
- 45
- Issue
- 6
- Pages
- 1721-1729
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2097667778
- Cited by
- 538
- References
- 22
- FWCI
- 55.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.